2026 Southeast Cardiovascular Disease Growth Intelligence
A 8-section executive intelligence brief on where cardiovascular disease provider and practice expansion is actually happening across the Southeast — and what a commercial team should do about it.
Source: CMS NPPES Data Dissemination, July 2026 (V2) full replacement file (records through 2026-07-12). Counts are of active NPI records, not estimates.
Inside the report
Preview — where capacity is being added
Newly registered NPIs in this specialty over the trailing 36 months, counted directly from the CMS NPPES registry. Full ranking included in the report.
This report tells you what happened in Southeast cardiovascular disease. NYSOM also identified 3,247 individual practices driving those changes, ranked by commercial opportunity. That part lives in NYSOM Copilot.
Get the free report
Tell us who you are and NYSOM will personalize the brief to your business before generating it.
The Southeast cardiovascular disease market in 2026
Commercial teams selling into cardiovascular disease keep asking the same question: how big is the Southeast cardiovascular disease market, and where is it adding capacity? This report answers that with counts, not estimates. As of the current CMS NPPES release there are 6,936 active cardiovascular disease providers and 3,251 cardiovascular disease organizations with a practice location in the Southeast. 368 cardiovascular disease NPIs in the region were first registered in the last 36 months.
Growth is not evenly distributed. Baltimore, Maryland recorded 52 newly registered cardiovascular disease NPIs over that window against 284 active providers — the kind of movement that changes where a territory should be pointed. The report ranks the metros in this region by that measure.
This is the free, market-level view, and it is built entirely from a public registry — anyone can verify it. The account-level view is where NYSOM Copilot works: which specific cardiovascular disease organizations registered new entities and new locations, what the signal was, and what your team should do about it.
Frequently asked questions
What does the Southeast Cardiovascular Disease report cover?
Active cardiovascular disease provider and organization counts for the Southeast (6,936 providers and 3,251 organizations at the current release), newly registered NPIs over the last 12 and 36 months, the metros adding the most new providers, the organizations that registered new entities in the last 24 months, and how many NPIs in the market report a parent organization.
Who is this cardiovascular disease market report for?
It is built for commercial leaders — VP Sales, Chief Commercial Officers, market access, and business development — at medical device, pharmaceutical, diagnostics, health IT, and services companies that sell into cardiovascular disease and need to know where to focus their territory and account effort.
Where does the data come from?
Every figure is counted directly from the CMS National Plan and Provider Enumeration System (NPPES) Data Dissemination — full replacement file (July 2026 (V2), records through 2026-07-12). Specialties are assigned using the CMS Medicare Provider and Supplier Taxonomy Crosswalk (October 2025). The registry is public, contains no protected health information, and the numbers in this report can be reproduced from it.
Is the cardiovascular disease report really free?
Yes. The full executive report is free with no sales call required. You can go further at any time with a free personalized Market Snapshot generated by NYSOM Copilot for your specific territory.